Clinical Trials
2 trialsNCT04758455 2021-02-17
The Use of Immunohistochemical Staining for the Prediction of Wilms Tumour Progression and Recurrence
Mansoura University
Phase NA Unknown
NCT00393029 2011-08-15
Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes
National Institutes of Health Clinical Center (CC)
Phase 2 Completed